Cover; Half Title; Title Page; Copyright Page; Dedication; Series Introduction; Preface; Table of Contents; Contributors; Part I. Respiratory Cancer; 1. Chemotherapy Resistance in Small Cell Lung Cancer: Consequences for the Clinician and Future Prospects; 2. Multidrug Resistance in Small Cell Lung Cancer; 3. Correlations Between Clinical Outcomes and In Vitro; 4. Liposomal Formulations of Chemotherapeutic Drugs; Part II. Breast Cancer; 5. Tamoxifen Resistance and Breast Cancer; 6. Resistance to Endocrine Therapy in Breast Cancer; 7. Heat Shock Proteins and Drug Resistance in Breast Cancer
Part III. Other Epithelial Cancers8. Overcoming Drug Resistance in Ovarian Cancer; 9. Protein Kinase C Activation and the Intrinsic Drug Resistance of Human Colon Cancer; Part IV. Hematological Malignancies; 10. Clinical Relevance of P-glycoprotein-Related Multidrug Resistance in Hematological Malignancies; 11. Prediction of Cytotoxic Drug Resistance in Acute Leukemia; Part V. Mechanisms of Drug Resistance; 12. Determinants of Estramustine Resistance; 13. Strategies for Overcoming Anthracycline Resistance; 14. Cellular Mechanisms of Cisplatin Resistance
15. Radiation Response in Chemotherapy-Resistant Tumors16. Preclinical In Vivo Models of Drug Resistance; Index
Summary
"This timely new reference integrates the latest clinical results and laboratory studies on the resistance of specific cancers to chemotherapeutic drugs-covering drug resistance in lung, breast, ovary, and colon cancer as well as hematological malignancies."--Provided by publisher
